Your search returned 2 results.

Results
	1.	Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals. [electronic resource] by Steudel, Wolfgang Dingmann, Colleen Zhang, Yan-Ling Bendrick-Peart, Jamie Clavijo, Claudia Shulze, John Betts, Ronald Christians, Uwe Producer: 20110323 In: Journal of clinical pharmacology vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. [electronic resource] by Tada, Norio Virmani, Renu Grant, Gordon Bartlett, Lauren Black, Alexander Clavijo, Claudia Christians, Uwe Betts, Ron Savage, Doug Su, Shih-Horng Shulze, John Kar, Saibal Producer: 20100914 In: Circulation. Cardiovascular interventions vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search